文献速递中毒与环境急症消化、代谢与肾脏急症

急性对乙酰氨基酚过量后连续检测改变列线图风险分区:一项回顾性数据库分析

Changing nomogram risk zone classification with serial testing after acute acetaminophen overdose: a retrospective database analysis.
PubMed 文献 · Clin Toxicol (Phila) · 2019-01-28
一句话结论急性对乙酰氨基酚过量患者中约半数在24小时内跨列线图风险分区,10.8%从150 μg/mL治疗线以下升至以上,支持连续检测直至肝损伤风险明确。

该研究为加拿大对乙酰氨基酚过量研究(CAOS)数据库的二次分析,纳入8个加拿大城市1980-2005年因急性对乙酰氨基酚过量住院且至少完成两次血清浓度检测的患者。采用有序逻辑回归分析人口学、摄入量/时间、对乙酰氨基酚浓度、至N-乙酰半胱氨酸(NAC)时间及合并摄入物对三级因变量(风险升高≥2个分区、保持同区或相邻区、风险降低≥2个分区)的影响。结果显示3201例次住院共7705次浓度检测中,52.5%在急性摄入24小时内至少跨一个分区,5.9%升高≥2个分区,16.1%降低≥2个分区;初始低于150 μg/mL治疗线的1251例中131例(10.8%)升至该线以上。年龄较大、男性及合并摄入阿片类、抗胆碱能药或NSAIDs与跨分区独立相关。结论支持连续检测对乙酰氨基酚浓度直至个体肝损伤风险明确。

要点

  • 3201例次住院中52.5%(1679例)在急性摄入24小时内至少跨一个列线图风险分区(升高或降低)。
  • 5.9%(190例)升高至少两个分区进入更高风险区,16.1%(516例)降低至少两个分区进入更低风险区。
  • 初始低于列线图治疗线150 μg/mL的1251例中,10.8%(131例)升至该线以上。
  • 年龄较大、男性、合并摄入阿片类、抗胆碱能药或NSAIDs与跨分区独立相关。
  • 作者结论支持连续检测对乙酰氨基酚浓度直至个体肝损伤风险明确建立。

适用人群与场景

  • 急性对乙酰氨基酚过量住院患者,且住院期间至少完成两次血清对乙酰氨基酚浓度检测。
  • 数据来自加拿大8个大城市1980-2005年住院患者的医疗记录回顾(CAOS数据库)。

诊断标准与关键阈值

  • Rumack-Matthew列线图将患者分为离散风险区,传统治疗决策基于初始风险区。
  • 列线图治疗线为150 μg/mL;初始低于该线的患者中10.8%升至该线以上。

研究设计与关键结果

  • 研究类型为CAOS数据库的二次分析(医疗记录回顾),纳入3201例次合格住院、共7705次对乙酰氨基酚浓度检测。
  • 3201例次中1679例(52.5%)在急性摄入24小时内至少跨一个分区(升高或降低)。
  • 190例(5.9%)升高至少两个分区进入更高风险区,516例(16.1%)降低至少两个分区进入更低风险区。
  • 初始低于列线图治疗线150 μg/mL的1251例中,131例(10.8%)升至该线以上。
  • 年龄较大、男性、合并摄入阿片类、抗胆碱能药或NSAIDs与跨分区独立相关。

证据类型、等级与局限

  • 证据类型:回顾性数据库分析(CAOS医疗记录回顾的二次分析)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论支持连续检测对乙酰氨基酚浓度直至个体肝损伤风险明确建立;传统基于初始风险区的治疗决策可能因跨分区而需重新评估。
  • 年龄较大、男性、合并摄入阿片类、抗胆碱能药或NSAIDs的患者跨分区风险更高。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

CONTEXT: The Rumack-Matthew nomogram stratifies patients into discrete risk zones following acetaminophen (APAP) overdose. Treatment decisions have traditionally been based on the initial risk zone. "Line-crossing" between zones occurs and is poorly understood. The study objective was to characterize line-crossing behavior in acute APAP overdose patients, especially moving from below to above the nomogram treatment threshold.

METHODS AND MATERIALS: The study was a secondary analysis of the Canadian Acetaminophen Overdose Study (CAOS) database, a large medical record review of patients hospitalized in eight large Canadian cities (1980-2005) following APAP poisoning. Population consisted of acute APAP overdose patients with at least two serum concentrations performed during hospitalization. Using ordinal logistic regression, we studied the effects of patient demographics, ingestion size/timing, APAP concentrations, time to N-acetylcysteine (NAC), and co-ingestants on a three-level dependent variable: patients whose risk increased two or more zones, those remaining in the same or adjacent zone, and those whose risk fell by two or more zones.

RESULTS: Of the 3201 eligible hospitalizations with 7705 APAP concentrations, half (1679, 52.5%) crossed at least one zone (up or down) within 24 h of acute ingestion, including 190 (5.9%), who crossed at least two lines into a higher risk zone, and 516 (16.1%) at least two lines into a lower risk zone. Of the 1251 patients initially below the nomogram treatment line of 150 μg/mL, 131 (10.8%) patients crossed above this line. Being older, male, and co-ingesting opioids, antimuscarinics, or NSAIDs were independently associated with line-crossing.

CONCLUSIONS: Patients commonly crossed nomogram risk zones, including from below to above the current treatment threshold. These findings support recommendations for serial APAP testing until the individual risk of hepatic injury is clearly established.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Mutsaers A, Green JP, Sivilotti MLA, et al. Changing nomogram risk zone classification with serial testing after acute acetaminophen overdose: a retrospective database analysis. Clin Toxicol (Phila). 2019. PMID: 30689438. doi:10.1080/15563650.2018.1529320

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。